United Therapeutics buy JPMorgan Chase & Co.
Start price
08.07.25
/
50%
€250.20
Target price
08.07.26
€281.09
Performance (%)
2.44%
Price
12.08.25
€258.30
Summary
This prediction is currently active. With a performance of 2.44%, the BUY prediction by JPMorgan_Chase___Co_ for United Therapeutics is trending in the right direction. This prediction currently runs until 08.07.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | -2.011% | -2.011% |
| iShares Core DAX® | 1.061% | -0.453% |
| iShares Nasdaq 100 | 2.615% | 4.747% |
| iShares Nikkei 225® | 5.693% | 9.002% |
| iShares S&P 500 | 1.433% | 3.156% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Corporation (NASDAQ: UTHR) had its price target lowered by analysts at JPMorgan Chase & Co. from $350.00 to $330.00. They now have an "overweight" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€260.00
01.05.25
01.05.25
€309.54
01.05.26
01.05.26
-0.65%
12.08.25
12.08.25
United Therapeutics
Start price
Target price
Perf. (%)
€255.00
21.04.25
21.04.25
€309.35
21.04.26
21.04.26
1.29%
12.08.25
12.08.25
United Therapeutics
Start price
Target price
Perf. (%)
€255.10
21.05.24
21.05.24
€276.33
21.05.25
21.05.25
6.82%
22.05.25
22.05.25